VELCADE 3.5 mg powder for solution for injection, Cyclophosphamide Tablets 50 mg, JNJ-54767414, Dexamethason 4 mg JENAPHARM®
54767414AMY3001
Phase 3 small_molecule active
Quick answer
VELCADE 3.5 mg powder for solution for injection, Cyclophosphamide Tablets 50 mg, JNJ-54767414, Dexamethason 4 mg JENAPHARM® for AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis) is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active